Suppr超能文献

高功率短时间消融指导下的消融指数或病变大小指数在心房颤动消融中的安全性和疗效:系统评价和荟萃分析。

Safety and Efficacy of High Power Shorter Duration Ablation Guided by Ablation Index or Lesion Size Index in Atrial Fibrillation Ablation: A Systematic Review and Meta-Analysis.

机构信息

Department of Cardiology, The First Affiliated Hospital of Guangxi Medical University, Nanning 530000, Guangxi, China.

出版信息

J Interv Cardiol. 2021 Jun 2;2021:5591590. doi: 10.1155/2021/5591590. eCollection 2021.

Abstract

BACKGROUND

High power shorter duration (HPSD) ablation may lead to safe and rapid lesion formation. However, the optimal radio frequency power to achieve the desired ablation index (AI) or lesion size index (LSI) is insubstantial. This analysis aimed to appraise the clinical safety and efficacy of HPSD guided by AI or LSI (HPSD-AI or LSI) in patients with atrial fibrillation (AF).

METHODS

The Medline, PubMed, Embase, Web of Science, and the Cochrane Library databases from inception to November 2020 were searched for studies comparing HPSD-AI or LSI and low power longer duration (LPLD) ablation.

RESULTS

Seven trials with 1013 patients were included in the analysis. The analyses verified that HPSD-AI or LSI revealed benefits of first-pass pulmonary vein isolation (PVI) (RR: 1.28; 95% CI: 1.05-1.56, P = 0.01) and acute pulmonary vein reconnection (PVR) (RR: 0.65; 95% CI: 0.48-0.88, P = 0.005) compared with LPLD. HPSD-AI or LSI showed higher freedom from atrial tachyarrhythmia (AT) (RR = 1.32, 95% CI: 1.14-1.53, P = 0.0002) in the subgroup analysis of studies with PVI ± (with or without additional ablation beyond PVI). HPSD-AI or LSI could short procedural time (WMD: -22.81; 95% CI, -35.03 to -10.60, P = 0.0003), ablation time (WMD: -10.80; 95% CI: -13.14 to -8.46, P < .00001), and fluoroscopy time (WMD: -7.71; 95% CI: -13.71 to -1.71, P = 0.01). Major complications and esophageal lesion in HPSD-AI or LSI group were no more than LDLP group (RR: 0.58; 95% CI: 0.20-1.69, P = 0.32) and (RR: 0.84; 95% CI: 0.43-1.61, P = 0.59).

CONCLUSIONS

HPSD-AI or LSI was efficient for treating AF with shorting procedural, ablation, and fluoroscopy time, higher first-pass PVI, and reducing acute PVR and may increase freedom from AT for patients with additional ablation beyond PVI compared with LPLD. Moreover, complications and esophageal lesion were low and no different between two groups.

摘要

背景

高功率短时间(HPSD)消融可能导致安全且快速的病变形成。然而,实现所需消融指数(AI)或病变大小指数(LSI)的最佳射频功率并不明确。本分析旨在评估 AI 或 LSI 指导下的 HPSD(HPSD-AI 或 LSI)在心房颤动(AF)患者中的临床安全性和疗效。

方法

从建库至 2020 年 11 月,检索 Medline、PubMed、Embase、Web of Science 和 Cochrane 图书馆数据库,比较 HPSD-AI 或 LSI 与低功率长时间(LPLD)消融的研究。

结果

纳入 7 项包含 1013 例患者的试验进行分析。分析结果证实,与 LPLD 相比,HPSD-AI 或 LSI 可提高初次肺静脉隔离(PVI)(RR:1.28;95%CI:1.05-1.56,P=0.01)和急性肺静脉再连接(PVR)(RR:0.65;95%CI:0.48-0.88,P=0.005)的成功率。亚组分析显示,在进行 PVI±(有或无 PVI 以外的附加消融)的研究中,HPSD-AI 或 LSI 组的无房性快速心律失常(AT)率更高(RR=1.32,95%CI:1.14-1.53,P=0.0002)。HPSD-AI 或 LSI 可缩短手术时间(WMD:-22.81;95%CI:-35.03 至-10.60,P=0.0003)、消融时间(WMD:-10.80;95%CI:-13.14 至-8.46,P<0.00001)和透视时间(WMD:-7.71;95%CI:-13.71 至-1.71,P=0.01)。HPSD-AI 或 LSI 组的主要并发症和食管损伤并不多于 LDLP 组(RR:0.58;95%CI:0.20-1.69,P=0.32)和(RR:0.84;95%CI:0.43-1.61,P=0.59)。

结论

与 LPLD 相比,HPSD-AI 或 LSI 可有效治疗 AF,缩短手术、消融和透视时间,提高初次 PVI 成功率,降低急性 PVR 发生率,增加 PVI 以外附加消融患者的无 AT 率。此外,两组的并发症和食管损伤发生率低且无差异。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6601/8192211/e940b0eaf1ab/JITC2021-5591590.001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验